A Phase 1/2 Study of Picoplatin and Docetaxel (With Prednisone) in Subjects With Chemotherapy-Naive Metastatic Hormone-Refractory Prostate Cancer
Phase of Trial: Phase I/II
Latest Information Update: 05 Mar 2010
At a glance
- Drugs Docetaxel; Picoplatin; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 05 Mar 2010 Final results presented at ASCO Genitourinary Cancers Symposium 2010.
- 05 Mar 2010 Status changed from active, no longer recruiting to completed based on presentation of final results.